WEGOVY
- Product NDC
- 0169-4501
- 11-digit product format
- 001694501
- Labeler code
- 0169
- Product ID
- 0169-4501_2cf550fd-3019-4202-b112-2009de398600
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- semaglutide
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Novo Nordisk Pharmaceutical Industries, LP
- Application
- NDA215256
- Marketing category
- NDA
- Marketing start
- 2021-06-05
- Substance
- SEMAGLUTIDE
- Active strength
- 1 mg/.5mL
- Pharmacologic classes
- GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N215256-001 | WEGOVY | SEMAGLUTIDE | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | |
| N215256-002 | WEGOVY | SEMAGLUTIDE | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | |
| N215256-003 | WEGOVY | SEMAGLUTIDE | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | |
| N215256-004 | WEGOVY | SEMAGLUTIDE | 1.7MG/0.75ML (1.7MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | |
| N215256-005 | WEGOVY | SEMAGLUTIDE | 2.4MG/0.75ML (2.4MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | |
| N215256-006 | WEGOVY HD | SEMAGLUTIDE | 7.2MG/0.75ML (7.2MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-03-19 | |
| N215256-007 | WEGOVY | SEMAGLUTIDE | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | |
| N215256-008 | WEGOVY | SEMAGLUTIDE | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | |
| N215256-009 | WEGOVY | SEMAGLUTIDE | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | |
| N215256-010 | WEGOVY | SEMAGLUTIDE | 1.7MG/0.75ML (1.7MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | |
| N215256-011 | WEGOVY | SEMAGLUTIDE | 2.4MG/0.75ML (2.4MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | |
| N215256-012 | WEGOVY FLEXTOUCH | SEMAGLUTIDE | 9.6MG/3ML (3.2MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-06-18 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N215256-001 | 8536122 | 2026-03-20 | Drug substance, Drug product | 2021-06-30 | |
| N215256-001 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2021-06-30 | |
| N215256-001 | 9764003 | 2033-06-21 | U-3161 | 2021-06-30 | |
| N215256-001 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2021-06-30 |
| N215256-001 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2023-10-10 |
| N215256-001 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2025-03-06 |
| N215256-001 | 11478533 | 2040-05-13 | U-3861 | 2025-09-03 | |
| N215256-001 | 11318191 | 2041-02-17 | U-3162 | Drug product | 2022-06-29 |
| N215256-002 | 8536122 | 2026-03-20 | Drug substance, Drug product | 2021-06-30 | |
| N215256-002 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2021-06-30 | |
| N215256-002 | 9764003 | 2033-06-21 | U-3161 | 2021-06-30 | |
| N215256-002 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2021-06-30 |
| N215256-002 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2023-10-10 |
| N215256-002 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2025-03-06 |
| N215256-002 | 11478533 | 2040-05-13 | U-3861 | 2025-09-03 | |
| N215256-002 | 11318191 | 2041-02-17 | U-3162 | Drug product | 2022-06-29 |
| N215256-003 | 8536122 | 2026-03-20 | Drug substance, Drug product | 2021-06-30 | |
| N215256-003 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2021-06-30 | |
| N215256-003 | 9764003 | 2033-06-21 | U-3161 | 2021-06-30 | |
| N215256-003 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2021-06-30 |
| N215256-003 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2023-10-10 |
| N215256-003 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2025-03-06 |
| N215256-003 | 11478533 | 2040-05-13 | U-3861 | 2025-09-03 | |
| N215256-003 | 11318191 | 2041-02-17 | U-3162 | Drug product | 2022-06-29 |
| N215256-004 | 8536122 | 2026-03-20 | Drug substance, Drug product | 2021-06-30 | |
| N215256-004 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2021-06-30 | |
| N215256-004 | 9764003 | 2033-06-21 | U-3161 | 2021-06-30 | |
| N215256-004 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2021-06-30 |
| N215256-004 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2023-10-10 |
| N215256-004 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2025-03-06 |
| N215256-004 | 11478533 | 2040-05-13 | U-3861 | 2025-09-03 | |
| N215256-004 | 11318191 | 2041-02-17 | U-3162 | Drug product | 2022-06-29 |
| N215256-005 | 8536122 | 2026-03-20 | Drug substance, Drug product | 2021-06-30 | |
| N215256-005 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2021-06-30 | |
| N215256-005 | 9764003 | 2033-06-21 | U-3161 | 2021-06-30 | |
| N215256-005 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2021-06-30 |
| N215256-005 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2023-10-10 |
| N215256-005 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2025-03-06 |
| N215256-005 | 12029779 | 2038-10-10 | U-3162 | 2024-07-09 | |
| N215256-005 | 12551536 | 2038-10-10 | U-4418 | 2026-03-02 | |
| N215256-005 | 11478533 | 2040-05-13 | U-3861 | 2025-09-03 | |
| N215256-005 | 11318191 | 2041-02-17 | U-3162 | Drug product | 2022-06-29 |
| N215256-006 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2026-03-31 | |
| N215256-006 | 9764003 | 2033-06-21 | U-4418 | 2026-03-31 | |
| N215256-006 | 10888605 | 2038-08-24 | U-4418 | Drug product | 2026-03-31 |
| N215256-006 | 11752198 | 2038-08-24 | U-4418 | Drug product | 2026-03-31 |
| N215256-006 | 12214017 | 2038-08-24 | U-4418 | Drug product | 2026-03-31 |
| N215256-006 | 12029779 | 2038-10-10 | U-4418 | 2026-03-31 | |
| N215256-006 | 12551536 | 2038-10-10 | U-4418 | 2026-03-31 | |
| N215256-006 | 11318191 | 2041-02-17 | U-4418 | Drug product | 2026-03-31 |
| N215256-007 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2026-06-23 | |
| N215256-007 | 9764003 | 2033-06-21 | U-3161 | 2026-06-23 | |
| N215256-007 | 12569543 | 2037-04-28 | U-4443 | 2026-06-23 | |
| N215256-007 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2026-06-23 |
| N215256-007 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2026-06-23 |
| N215256-007 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2026-06-23 |
| N215256-007 | 12029779 | 2038-10-10 | U-3162 | 2026-06-23 | |
| N215256-007 | 12551536 | 2038-10-10 | U-4418 | 2026-06-23 | |
| N215256-007 | 11478533 | 2040-05-13 | U-3861 | 2026-06-23 | |
| N215256-007 | 11318191 | 2041-02-17 | U-3162 | Drug product | 2026-06-23 |
| N215256-007 | 11318191 | 2041-02-17 | U-4443 | Drug product | 2026-06-23 |
| N215256-007 | 11318191 | 2041-02-17 | U-4560 | Drug product | 2026-06-23 |
| N215256-008 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2026-06-23 | |
| N215256-008 | 9764003 | 2033-06-21 | U-3161 | 2026-06-23 | |
| N215256-008 | 12569543 | 2037-04-28 | U-4443 | 2026-06-23 | |
| N215256-008 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2026-06-23 |
| N215256-008 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2026-06-23 |
| N215256-008 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2026-06-23 |
| N215256-008 | 12029779 | 2038-10-10 | U-3162 | 2026-06-23 | |
| N215256-008 | 12551536 | 2038-10-10 | U-4418 | 2026-06-23 | |
| N215256-008 | 11478533 | 2040-05-13 | U-3861 | 2026-06-23 | |
| N215256-008 | 11318191 | 2041-02-17 | U-3162 | Drug product | 2026-06-23 |
| N215256-008 | 11318191 | 2041-02-17 | U-4443 | Drug product | 2026-06-23 |
| N215256-008 | 11318191 | 2041-02-17 | U-4560 | Drug product | 2026-06-23 |
| N215256-009 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2026-06-23 | |
| N215256-009 | 9764003 | 2033-06-21 | U-3161 | 2026-06-23 | |
| N215256-009 | 12569543 | 2037-04-28 | U-4443 | 2026-06-23 | |
| N215256-009 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2026-06-23 |
| N215256-009 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2026-06-23 |
| N215256-009 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2026-06-23 |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N215256-001 | I-935 | 2027-03-08 |
| N215256-001 | I-973 | 2028-08-15 |
| N215256-002 | I-935 | 2027-03-08 |
| N215256-002 | I-973 | 2028-08-15 |
| N215256-003 | I-935 | 2027-03-08 |
| N215256-003 | I-973 | 2028-08-15 |
| N215256-004 | D-190 | 2026-07-21 |
| N215256-004 | I-935 | 2027-03-08 |
| N215256-004 | I-973 | 2028-08-15 |
| N215256-005 | I-935 | 2027-03-08 |
| N215256-005 | I-973 | 2028-08-15 |
| N215256-006 | NS | 2029-03-19 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N215256-001 | WEGOVY | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-002 | WEGOVY | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-003 | WEGOVY | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-004 | WEGOVY | 1.7MG/0.75ML (1.7MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-005 | WEGOVY | 2.4MG/0.75ML (2.4MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-001 | WEGOVY | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-002 | WEGOVY | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-003 | WEGOVY | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-004 | WEGOVY | 1.7MG/0.75ML (1.7MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-005 | WEGOVY | 2.4MG/0.75ML (2.4MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-001 | WEGOVY | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-002 | WEGOVY | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-003 | WEGOVY | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-004 | WEGOVY | 1.7MG/0.75ML (1.7MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-005 | WEGOVY | 2.4MG/0.75ML (2.4MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N215256-001 | WEGOVY | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N215256-002 | WEGOVY | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N215256-003 | WEGOVY | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N215256-004 | WEGOVY | 1.7MG/0.75ML (1.7MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N215256-005 | WEGOVY | 2.4MG/0.75ML (2.4MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N215256-001 | WEGOVY | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N215256-002 | WEGOVY | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N215256-003 | WEGOVY | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N215256-004 | WEGOVY | 1.7MG/0.75ML (1.7MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N215256-005 | WEGOVY | 2.4MG/0.75ML (2.4MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N215256-001 | WEGOVY | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N215256-002 | WEGOVY | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N215256-003 | WEGOVY | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N215256-004 | WEGOVY | 1.7MG/0.75ML (1.7MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N215256-005 | WEGOVY | 2.4MG/0.75ML (2.4MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N215256-001 | WEGOVY | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N215256-002 | WEGOVY | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N215256-003 | WEGOVY | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N215256-004 | WEGOVY | 1.7MG/0.75ML (1.7MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N215256-005 | WEGOVY | 2.4MG/0.75ML (2.4MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N215256-001 | WEGOVY | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N215256-002 | WEGOVY | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N215256-003 | WEGOVY | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N215256-004 | WEGOVY | 1.7MG/0.75ML (1.7MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N215256-005 | WEGOVY | 2.4MG/0.75ML (2.4MG/0.75ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2021-06-04 | 5bbf6a4d5a75… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N215256-001 | 8536122 | 2026-03-20 | Drug substance, Drug product | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-001 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-001 | 9764003 | 2033-06-21 | U-3161 | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-001 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2021-06-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-001 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2023-10-10 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-001 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2025-03-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-001 | 11478533 | 2040-05-13 | U-3861 | 2025-09-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-001 | 11318191 | 2041-02-17 | U-3162 | Drug product | 2022-06-29 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-002 | 8536122 | 2026-03-20 | Drug substance, Drug product | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-002 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-002 | 9764003 | 2033-06-21 | U-3161 | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-002 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2021-06-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-002 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2023-10-10 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-002 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2025-03-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-002 | 11478533 | 2040-05-13 | U-3861 | 2025-09-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-002 | 11318191 | 2041-02-17 | U-3162 | Drug product | 2022-06-29 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-003 | 8536122 | 2026-03-20 | Drug substance, Drug product | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-003 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-003 | 9764003 | 2033-06-21 | U-3161 | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-003 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2021-06-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-003 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2023-10-10 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-003 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2025-03-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-003 | 11478533 | 2040-05-13 | U-3861 | 2025-09-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-003 | 11318191 | 2041-02-17 | U-3162 | Drug product | 2022-06-29 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-004 | 8536122 | 2026-03-20 | Drug substance, Drug product | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-004 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-004 | 9764003 | 2033-06-21 | U-3161 | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-004 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2021-06-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-004 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2023-10-10 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-004 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2025-03-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-004 | 11478533 | 2040-05-13 | U-3861 | 2025-09-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-004 | 11318191 | 2041-02-17 | U-3162 | Drug product | 2022-06-29 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-005 | 8536122 | 2026-03-20 | Drug substance, Drug product | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-005 | 8129343 | 2031-12-05 | Drug substance, Drug product | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-005 | 9764003 | 2033-06-21 | U-3161 | 2021-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-005 | 10888605 | 2038-08-24 | U-3162 | Drug product | 2021-06-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-005 | 11752198 | 2038-08-24 | U-3162 | Drug product | 2023-10-10 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-005 | 12214017 | 2038-08-24 | U-3162 | Drug product | 2025-03-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-005 | 12029779 | 2038-10-10 | U-3162 | 2024-07-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-005 | 11478533 | 2040-05-13 | U-3861 | 2025-09-03 | 011fe1cb6892… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N215256-001 | I-935 | 2027-03-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-001 | I-973 | 2028-08-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-002 | I-935 | 2027-03-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-002 | I-973 | 2028-08-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-003 | I-935 | 2027-03-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-003 | I-973 | 2028-08-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-004 | D-190 | 2026-07-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-004 | I-935 | 2027-03-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-004 | I-973 | 2028-08-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-005 | I-935 | 2027-03-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N215256-005 | I-973 | 2028-08-15 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-001 | NPP | 2025-12-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-001 | I-935 | 2027-03-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-001 | I-973 | 2028-08-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-002 | NPP | 2025-12-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-002 | I-935 | 2027-03-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-002 | I-973 | 2028-08-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-003 | NPP | 2025-12-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-003 | I-935 | 2027-03-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-003 | I-973 | 2028-08-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-004 | NPP | 2025-12-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-004 | D-190 | 2026-07-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-004 | I-935 | 2027-03-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-004 | I-973 | 2028-08-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-005 | NPP | 2025-12-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-005 | I-935 | 2027-03-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N215256-005 | I-973 | 2028-08-15 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-001 | NPP | 2025-12-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-001 | I-935 | 2027-03-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-002 | NPP | 2025-12-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-002 | I-935 | 2027-03-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-003 | NPP | 2025-12-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-003 | I-935 | 2027-03-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-004 | NPP | 2025-12-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-004 | D-190 | 2026-07-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-004 | I-935 | 2027-03-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-005 | NPP | 2025-12-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N215256-005 | I-935 | 2027-03-08 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N215256-001 | NPP | 2025-12-23 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N215256-001 | I-935 | 2027-03-08 | fd3edfee7708… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- WEGOVY
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SEMAGLUTIDE | 1 mg/.5mL |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 9dd2abc7-744f-456b-a273-dec083824bd8 | Product name | 2 | 20240229 |
| 487bac84-7c5b-40cf-afd2-8b9674d4648e | Product name | 1 | 20220118 |
| 21318a8d-e167-4f44-9627-3daede9532ff | Product name | 1 | 20200227 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0169-4501-01 | WEGOVY | 0.5 mL in 1 SYRINGE, PLASTIC | INJECTION, SOLUTION | 0.5 | 18 | |
| 0169-4501-14 | WEGOVY | 4 in 1 CARTON | INJECTION, SOLUTION | 4 | 18 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0169-4501-14 | ML - Milliliter | 0169-4501 | 6837bda9-cc73-4acb-bc71-3e13724ae262 | 1 | 2021-07-15 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| WEGOVY | SEMAGLUTIDE | A-S Medication Solutions | f5e548d0-cc79-4c34-a3f5-e20a5b8b6564 | 2024-04-23 | Boxed warning, Warnings, Adverse reactions | 215256 NDA215256 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2553501 | semaglutide 0.25 MG in 0.5 ML Auto-Injector | PSN | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2553601 | semaglutide 0.5 MG in 0.5 ML Auto-Injector | PSN | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2553802 | semaglutide 1 MG in 0.5 ML Auto-Injector | PSN | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2707547 | semaglutide 1.5 MG Oral Tablet | PSN | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2553901 | semaglutide 1.7 MG in 0.75 ML Auto-Injector | PSN | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2554102 | semaglutide 2.4 MG in 0.75 ML Auto-Injector | PSN | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2730163 | semaglutide 25 MG Oral Tablet | PSN | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2707551 | semaglutide 4 MG Oral Tablet | PSN | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2739768 | semaglutide 7.2 MG in 0.75 ML Auto-Injector | PSN | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2707555 | semaglutide 9 MG Oral Tablet | PSN | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2553506 | wegovy 0.25 MG in 0.5 ML Auto-Injector | PSN | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2553603 | wegovy 0.5 MG in 0.5 ML Auto-Injector | PSN | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2553803 | wegovy 1 MG in 0.5 ML Auto-Injector | PSN | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2730161 | wegovy 1.5 MG Oral Tablet | PSN | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2553903 | wegovy 1.7 MG in 0.75 ML Auto-Injector | PSN | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2554104 | wegovy 2.4 MG in 0.75 ML Auto-Injector | PSN | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2730165 | wegovy 25 MG Oral Tablet | PSN | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2730167 | wegovy 4 MG Oral Tablet | PSN | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2730169 | wegovy 9 MG Oral Tablet | PSN | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2739771 | wegovy HD 7.2 MG in 0.75 ML Auto-Injector | PSN | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2553506 | 0.5 ML semaglutide 0.5 MG/ML Auto-Injector [Wegovy] | SBD | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2553603 | 0.5 ML semaglutide 1 MG/ML Auto-Injector [Wegovy] | SBD | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2553803 | 0.5 ML semaglutide 2 MG/ML Auto-Injector [Wegovy] | SBD | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2553903 | 0.75 ML semaglutide 2.27 MG/ML Auto-Injector [Wegovy] | SBD | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2554104 | 0.75 ML semaglutide 3.2 MG/ML Auto-Injector [Wegovy] | SBD | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2739771 | 0.75 ML semaglutide 9.6 MG/ML Auto-Injector [Wegovy] | SBD | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2730161 | semaglutide 1.5 MG Oral Tablet [Wegovy] | SBD | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2730165 | semaglutide 25 MG Oral Tablet [Wegovy] | SBD | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2730167 | semaglutide 4 MG Oral Tablet [Wegovy] | SBD | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2730169 | semaglutide 9 MG Oral Tablet [Wegovy] | SBD | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2553501 | 0.5 ML semaglutide 0.5 MG/ML Auto-Injector | SCD | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2553601 | 0.5 ML semaglutide 1 MG/ML Auto-Injector | SCD | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2553802 | 0.5 ML semaglutide 2 MG/ML Auto-Injector | SCD | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2553901 | 0.75 ML semaglutide 2.27 MG/ML Auto-Injector | SCD | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2554102 | 0.75 ML semaglutide 3.2 MG/ML Auto-Injector | SCD | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2739768 | 0.75 ML semaglutide 9.6 MG/ML Auto-Injector | SCD | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2707547 | semaglutide 1.5 MG Oral Tablet | SCD | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2730163 | semaglutide 25 MG Oral Tablet | SCD | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2707551 | semaglutide 4 MG Oral Tablet | SCD | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2707555 | semaglutide 9 MG Oral Tablet | SCD | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2553501 | semaglutide 0.25 MG per 0.5 ML Auto-Injector | SY | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2553601 | semaglutide 0.5 MG per 0.5 ML Auto-Injector | SY | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2553802 | semaglutide 1 MG per 0.5 ML Auto-Injector | SY | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2553901 | semaglutide 1.7 MG per 0.75 ML Auto-Injector | SY | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2554102 | semaglutide 2.4 MG per 0.75 ML Auto-Injector | SY | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2739768 | semaglutide 7.2 MG per 0.75 ML Auto-Injector | SY | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2739768 | semaglutide 9.6 MG/ML per 0.75 ML Auto-Injector | SY | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2553506 | Wegovy 0.25 MG per 0.5 ML Auto-Injector | SY | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2553603 | Wegovy 0.5 MG per 0.5 ML Auto-Injector | SY | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2553803 | Wegovy 1 MG per 0.5 ML Auto-Injector | SY | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2730161 | Wegovy 1.5 MG Oral Tablet | SY | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2553903 | Wegovy 1.7 MG per 0.75 ML Auto-Injector | SY | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2554104 | Wegovy 2.4 MG per 0.75 ML Auto-Injector | SY | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2730165 | Wegovy 25 MG Oral Tablet | SY | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2730167 | Wegovy 4 MG Oral Tablet | SY | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2739771 | Wegovy 7.2 MG per 0.75 ML Auto-Injector | SY | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2730169 | Wegovy 9 MG Oral Tablet | SY | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
| 2739771 | Wegovy 9.6 MG/ML per 0.75 ML Auto-Injector | SY | ee06186f-2aa3-4990-a760-757579d8f77b | 18 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0169-4501-01 | 00169450101 | 0.5 mL in 1 SYRINGE, PLASTIC | 0.5 ml | Historical | ||||
| 0169-4501-14 | 00169450114 | 4 SYRINGE, PLASTIC in 1 CARTON (0169-4501-14) / .5 mL in 1 SYRINGE, PLASTIC (0169-4501-01) | 2021-06-05 | 0000-00-00 | No | No | Current |